PRPOPrecipio, Inc.

NAS · US · Healthcare · Diagnostics & Research · precipiodx.com

30.45USD+9.34%Mkt Cap: 54.51M $P/E: —3d ago

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap54.51M $

Enterprise Value42.89M $

Revenue (TTM)25.83M $

Gross Profit10.71M $

Net Income (TTM)-363.00K $

Revenue/Share15.42 USD

Last Price30.45 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees61

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS74019L5030

Valuation

P/E (Trailing)—

P/E (Forward)75.46

PEG—

EV/EBITDA-120.48

EV/Revenue1.66

P/S2.04

P/B3.60

EPS (TTM)-0.66

EPS (Forward)0.39

52W Range

13.8084% of range33.63

52W High33.63 USD

52W Low13.80 USD

Profitability

Gross Margin44.52%

Oper. Margin-21.28%

EBITDA Margin-1.38%

Profit Margin-1.51%

ROE-2.49%

ROA-1.70%

Growth

Revenue Growth36.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF793.00K $

CapEx (TTM)326.00K $

FCF Margin2.49%

FCF Yield1.18%

Net Debt888.00K $

Net Debt/EBITDA-2.49

Balance Sheet

Debt/Equity0.25

Current Ratio1.56

Quick Ratio1.21

Book Value/Sh8.176 USD

Cash/Share1.457 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateApr 29, 2019

Splits

Last Split1:20

Split DateSep 22, 2023

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.79M

Float1.40M

Insiders12.65%

Institutions17.74%

Short Interest

Short Ratio0.4d

Short % Float2.29%

Short % Out.2.08%

Shares Short37.18K

Short (prev mo.)27.43K

Technical

SMA 5023.66 (+28.7%)

SMA 20024.64 (+23.6%)

Beta1.29

S&P 52W Chg18.16%

Avg Vol (30d)115.79K

Avg Vol (10d)178.42K

Technical Indicators

RSI (14)75.9

MACD0.7836

MACD Signal0.0323

MACD Hist.+0.7512

BB Upper27.71 USD

BB Middle23.45 USD

BB Lower19.19 USD

BB Width36.30%

ATR (14)1.988 USD

Vol Ratio (20d)0.63x